$MBLY

Mobileye Global Inc. Q3 2026 Earnings Call Summary

Mobileye Global Inc. raised its 2026 revenue guidance to $2.008 billion, citing higher SuperVision deliveries. The company is transitioning to comprehensive ADAS systems and expects EyeQ ASPs to stabilize in 2027. Q3 saw $51 million in R&D incentives boosting margins to 18%. Management confirmed on-track production programs with Volkswagen and plans for 2027 robotaxi commercialization.

Original reporting
Published Oct 29, 2026, 10:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mobileye Global Inc. Q3 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$MBLYBullishMed
01

Why it matters

Traders can update 2026 revenue expectations from the raised midpoint guidance and reassess margin trajectory using the described contra-R&D benefit and memory cost pass-through mechanics. The forecasted Q4 step-down and ASP stabilization assumptions frame near-term risk.

02

Market read

Raised 2026 revenue guidance plus detailed margin and Q4 revenue expectations create a tradable update to near-term fundamentals, even though robotaxi commercialization remains a longer-dated catalyst.

03

What to watch

Robotaxi commercialization details are still early (100-vehicle Florida deployment in 2027), so execution risk and hardware cost assumptions could dominate the stock reaction despite strategic optimism.

Relevance 7/10Novelty 6/10Timing: after-hours earnings call summary, positioning for next trading session

Background

The piece summarizes Mobileye’s Q3 2026 earnings call, focusing on EyeQ shipment momentum, ADAS system expansion, robotaxi strategy, and updated financial outlook.

Company-level read

Ticker impact

$MBLYBullishMedium confidence
Context

Mobileye raised full-year 2026 revenue guidance to about $2.008B midpoint, citing higher SuperVision deliveries and memory cost pass-throughs.

Expected impact

Likely upward bias as traders price in the raised 2026 revenue outlook, offset by caution around the forecasted Q4 revenue step-down and gross margin headwinds.

Evidence & confidence

The article provides specific guidance and margin drivers (contra-R&D benefit, memory pass-through, Q4 step-down) that can shift earnings expectations and valuation multiples.

Market effects

Reinforces the ADAS and robotaxi software monetization narrative, with emphasis on higher-value bundles (Surround ADAS, Cloud-Enhanced ADAS) and vertically integrated validation.

Highlights Chinese OEM selection as a growth catalyst for export credibility, potentially affecting competitive dynamics in emerging markets.

Supports broader investor focus on autonomy stack economics (software licensing, validation cycles) rather than only sensor hardware.

Counterpoint

The raised guidance may be partially offset by timing and margin normalization risks, especially with the forecasted Q4 revenue step-down and gross margin pressure from memory pass-throughs.

Key entities

  • Mobileye Global Inc.

    EyeQ/ADAS supplier raising 2026 revenue guidance and outlining 2027 robotaxi commercialization and next-gen ADAS monetization.

  • Volkswagen Group

    Management discusses ongoing production programs and how CARIAD partner shifts do not affect Mobileye’s current nominations.

  • CARIAD

    Management says CARIAD’s search for a new partner is separate from Mobileye’s current production nominations.

Related articles

$MBLYMed

Piper Sandler reiterates Mobileye stock rating at overweight

Piper Sandler maintained an Overweight rating and $12.00 price target for Mobileye (MBLY) after its Q3 results beat expectations. The company's 2026 guidance increased but less than anticipated. Mobileye's stock is down 51% year-over-year, trading at $6.41. Piper Sandler noted risks like Chinese competition but expects higher-value ADAS sales to benefit Mobileye's P&L starting 2027. TD Cowen downgraded MBLY to Hold with a $7.00 price target, citing delays and partner challenges.

$MBLYMed

TD Cowen downgrades Mobileye stock rating on delayed timelines

TD Cowen downgraded Mobileye (MBLY) to Hold from Buy, lowering its price target to $7.00. The firm cited delayed timelines and headwinds with Western partners. Mobileye's Q3 2026 earnings missed expectations, with adjusted EPS of $0.11 and revenue of $492 million, down 2% YoY. The stock is near its 52-week low of $6.37, down 50% over the past year.

$MBLYMedAI 8/10

Mobileye Global Q3 Earnings Call Highlights

Mobileye (MBLY) raised its 2023 revenue outlook to $2.008B and adjusted operating income to $400M, citing strong SuperVision deliveries. Q3 adjusted operating margin was 18%, up 3% YoY. The company expects 4.5M chips to be delivered to China by 2026 and sees growth in ADAS adoption.